For the Inventor, By the Inventor

Enter assignee name

Palo Alto, CA, United States of America

Systemix, Inc.

USPTO Granted Patents = 48

EPO Patents = 1

Forward Citations = 2,039

Loading Chart...

Loading Chart...

57 inventors (with patents filed for the assignee):

Hideto Kaneshima (9 out of 9 patents)

Joseph M McCune (9 out of 16 patents)

Irving L Weissman (7 out of 149 patents)

4. Reiko Namikawa (7 out of 7 patents)

5. Ann Tsukamoto (7 out of 7 patents)

6. Steven M Torkelson (6 out of 10 patents)

7. Yukoh Aihara (6 out of 6 patents)

8. Charles M Baum (6 out of 6 patents)

9. Richard Schwartz (4 out of 21 patents)

10. Robert J Kaiser (4 out of 18 patents)

11. Kevin P Lund (4 out of 21 patents)

12. Anne H Galy (4 out of 4 patents)

13. Lesley J Murray (3 out of 6 patents)

14. Mark L Bonyhadi (3 out of 3 patents)

15. Michael H Vardanega (2 out of 10 patents)

Core Competencies:

Hematopoietic Stem Cells

Cell Separation

Gene Transfer

Flow Cytometry

Antiviral Agents

Stem Cell Expansion

Bioreactors

Fluorescent Labeling

High Gradient Magnetic Device

Human Growth Factors

Drug Screening

Dendritic Cells

48 patents: Sort by Forward Citations

1. 6326205 - Methods for use of Mpl ligands with primitive human stem cells (2001-12-04),

2. 6241894 - High gradient magnetic device and method for cell separation or purification (2001-06-05),

3. 6228609 - Soluble Flk-2 sequence (2001-05-08),

4. 6093872 - Extended human hematopoiesis in a heterologous host (2000-07-25),

5. 6060052 - Methods for use of Mpl ligands with primitive human hematopoietic stem (2000-05-09),

6. 6017761 - Method for obtaining retroviral packaging cell lines producing high (2000-01-25),

7. 6015554 - Method of reconstituting human lymphoid and dendritic cells (2000-01-18),

8. 5985660 - Method of identifying biological response modifiers involved in (1999-11-16),

9. 5972627 - Method of purifying a population of cells enriched for dendritic and/or (1999-10-26),

10. 5955612 - Fluorescent labeling reagents (1999-09-21),

11. 5928638 - Methods for gene transfer (1999-07-27),

12. 5914108 - Human hematopoietic stem cell (1999-06-22),

13. 5910434 - Method for obtaining retroviral packaging cell lines producing high (1999-06-08),

14. 5869623 - Boronic compound complexing reagents and complexes (1999-02-09),

15. 5859210 - Boronic compound complexing reagents and complexes (1999-01-12),

Company Overview

Systemix, Inc., based in Palo Alto, CA, specializes in advanced biotechnological solutions focusing on hematopoietic stem cells and cell separation techniques. The company is at the forefront of developing innovative applications in flow cytometry and gene transfer, contributing to the fields of regenerative medicine and therapeutic interventions. Additionally, Systemix explores the potential of antiviral agents and human growth factors, alongside utilizing xenogeneic tissue and bioreactors to enhance research and clinical outcomes in cellular therapies.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

48 Patents

#43 in Palo Alto, CA

#1,715 in California

#7,288 in US

#14,561 in the World

Palo Alto, CA, United States of America

Systemix, Inc.

Forward Citations = 2,039

57 inventors:

Hideto Kaneshima (9 out of 9 patents)

Joseph M McCune (9 out of 16 patents)

Irving L Weissman (7 out of 149 patents)

4. Reiko Namikawa (7 out of 7 patents)

5. Ann Tsukamoto (7 out of 7 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Systemix, Inc.. Retrieved from https://idiyas.com/company/systemix

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…